Y-Intercept (HK)’s Theravance Biopharma TBPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$452K Buy
+40,943
New +$452K 0.01% 1239
2024
Q4
Sell
-31,194
Closed -$251K 1643
2024
Q3
$251K Buy
+31,194
New +$251K 0.02% 1078
2023
Q4
Sell
-16,137
Closed -$139K 1632
2023
Q3
$139K Buy
+16,137
New +$139K 0.01% 941